震有科技(688418.SH)首次發行4841萬股新股 發行價16.25元/股
格隆匯7月20日丨震有科技(688418.SH)公佈,公司股票將於2020年7月22日在上海證券交易所科創板上市,首次公開發行不超過4841萬股人民幣普通股(A股),發行價格為16.25元/股。本次發行後公司總股本為1.94億股,其中3943.45萬股股票將於2020年7月22日起上市交易。
本次發行募集資金總額7.866億元,全部為公司公開發行新股募集,本次發行募集資金淨額為7.13億元。募集資金扣除發行費用後全部用於下一代互聯網寬帶接入設備開發項目、5G核心網設備開發項目、應急指揮及決策分析系統開發項目、產品研究開發中心建設項目等。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.